Titre :
  • A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Auteur : Catimel, G ; Vermorken, Jan Baptist ; Clavel, Michel ; de Mulder, Pieter ; Judson, I R ; Sessa, C ; Piccart-Gebhart, Martine ; Bruntsch, U ; Verweij, Jaap ; Wanders, Jantien
Informations sur la publication : Annals of oncology, 5, 6, (page 543-547)
Statut de publication : Publié, 1994-07
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Alanine Transaminase -- blood
Antimetabolites, Antineoplastic -- administration & dosage
Antimetabolites, Antineoplastic -- adverse effects
Antimetabolites, Antineoplastic -- therapeutic use
Aspartate Aminotransferases -- blood
Carcinoma, Squamous Cell -- drug therapy
Deoxycytidine -- administration & dosage
Deoxycytidine -- adverse effects
Deoxycytidine -- analogs & derivatives
Deoxycytidine -- therapeutic use
Europe
Fatigue -- chemically induced
Female
Head and Neck Neoplasms -- drug therapy
Humans
Liver -- drug effects
Liver -- enzymology
Male
Middle Aged
Neutropenia -- chemically induced
Remission Induction
Note : Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:pmid/7918127